V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression
- PMID: 9393757
V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression
Abstract
Adaptation to hypoxia represents an important aspect of tumor progression. Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that mediates essential homeostatic responses to cellular and systemic hypoxia by activating transcription of multiple genes including those encoding glycolytic enzymes and vascular endothelial growth factor (VEGF). In this report, we demonstrate that whereas C-SRC expression is not required for expression of HIF-1 or transcriptional activation of genes encoding VEGF and enolase 1 (ENO1), cells expressing the v-Src oncogene have increased expression of HIF-1, VEGF, and ENO1 under both hypoxic and nonhypoxic conditions. Expression of V-SRC was associated with increased transcription of reporter genes containing cis-acting hypoxia-response elements from the VEGF and ENO1 genes, and this transcriptional activation required an intact HIF-1 binding site. When three rat hepatoma subclones that differed with respect to the level of HIF-1 expression were injected into nude mice, tumor growth correlated with HIF-1 expression, suggesting that HIF-1 may be generally involved in tumor progression. These studies link an oncogene to the induction of HIF-1 expression, thus providing a mechanism for hypoxic adaptation by tumor cells.
Similar articles
-
Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.Clin Cancer Res. 2001 May;7(5):1263-72. Clin Cancer Res. 2001. PMID: 11350893
-
Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.Cancer Res. 2002 Aug 1;62(15):4316-24. Cancer Res. 2002. PMID: 12154035
-
Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms.Cancer Res. 1997 Sep 1;57(17):3860-4. Cancer Res. 1997. PMID: 9288800
-
[Hypoxia and tumors: does HIF-1 transcription factor favor tumor growth or hypoxia?].Bull Cancer. 1998 Oct;85(10):843-5. Bull Cancer. 1998. PMID: 9835861 Review. French.
-
HIF-1 and AP-1 cooperate to increase gene expression in hypoxia: role of MAP kinases.IUBMB Life. 2001 Jul;52(1-2):49-53. doi: 10.1080/15216540252774766. IUBMB Life. 2001. PMID: 11795593 Review.
Cited by
-
The impact of hypoxia in pancreatic cancer invasion and metastasis.Hypoxia (Auckl). 2014 Jul 16;2:91-106. doi: 10.2147/HP.S52636. eCollection 2014. Hypoxia (Auckl). 2014. PMID: 27774469 Free PMC article. Review.
-
MYBPC3 deficiency in cardiac fibroblasts drives their activation and contributes to fibrosis.Cell Death Dis. 2022 Nov 10;13(11):948. doi: 10.1038/s41419-022-05403-6. Cell Death Dis. 2022. PMID: 36357371 Free PMC article.
-
A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1.Cell Death Dis. 2018 Dec 5;9(12):1184. doi: 10.1038/s41419-018-1231-4. Cell Death Dis. 2018. PMID: 30518748 Free PMC article.
-
Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.Br J Cancer. 2001 Sep 14;85(6):881-90. doi: 10.1054/bjoc.2001.2018. Br J Cancer. 2001. PMID: 11556841 Free PMC article.
-
Expression of hypoxia-inducible factor (HIF)-1alpha as a biomarker of outcome in soft-tissue sarcomas.Virchows Arch. 2006 Dec;449(6):673-81. doi: 10.1007/s00428-006-0304-4. Epub 2006 Nov 14. Virchows Arch. 2006. PMID: 17103226
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous